Westside Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Westside Investment Management's AZN Position: Q2 2026 in Review
Westside Investment Management held its AstraZeneca (AZN) position steady in Q2 2026 at 779 shares worth $148K. The position accounts for 0.02% of the portfolio, ranked #353.
Westside Investment Management first reported a position in AZN in Q2 2020 and has held it in 25 quarters since. The position peaked at $156K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Westside Investment Management held 779 shares of AstraZeneca worth $148K as of Q2 2026.
- Westside Investment Management left its AstraZeneca share count unchanged in Q2 2026.
- AstraZeneca made up 0.02% of Westside Investment Management's portfolio in Q2 2026, its #353 holding.
- Westside Investment Management first reported a position in AstraZeneca in Q2 2020 and has held it in 25 quarters since.
- Westside Investment Management's AstraZeneca position peaked at $156K in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.